We are monitoring the impact of COVID-19 on APAC Autoinjectors Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5831
Share on
Share on

Asia Pacific Autoinjectors Market Research Report – Segmented By Product, Usability, Manufacturing Design, Technology, Application, Distribution Channels, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 5831
Pages: 145

APAC Autoinjectors Market Size (2021 to 2026)

The Asia Pacific Autoinjectors Market size is estimated to grow from USD 0.52 billion in 2021 to USD 1.20 billion by 2026, registering a CAGR of 18.2% during the forecast period.

The rising prevalence of targeted therapies, the rising incidence of anaphylaxis, the rising preference for self-administration of drugs, favorable reimbursements, and government support, usability benefits, the growing number of regulatory approvals, the availability of generic versions of autoinjectors, and technological advancements are some of the significant factors promoting Asia pacific autoinjectors market growth. Autoinjectors are favored over traditional devices because they allow for more efficient and better medication administration and the development of novel formulations. In addition, product technological advances are expected to drive growth to the market. Autoinjectors provide several benefits, including lowering the risk of needle-related anxiety conditions, reducing needle-stick accidents, preserving dosage quality precision, and enhancing effectiveness. As a result of these benefits, the use of the Asia pacific autoinjectors market is accelerating.

The removal force of the safety cap, needle activation force, override force, ejection dosage, needle length, ejection time, dose setting, and auditory click detection are all factors examined while improving autoinjectors. Autoinjector use is projected to increase in the future years as a result of such technical developments. Autoinjectors are being developed to enable higher viscosity and drug concentrations to minimize medication administration frequency and improve adherence to approved treatment regimens. In the current COVID-19 environment, these elements provide an opportunity for the autoinjector industry to develop. The benefits of usability are fueling the Asia Pacific market, the rising number of regulatory approvals, and the availability of standard versions of autoinjectors, as well as favorable settlements relating to autoinjectors. Furthermore, government initiatives and technology developments are expected to make this market more advantageous. Biologics' patent expiration is expected to open up new growth opportunities for the market. The transition from biologics to biosimilars administered by autoinjectors is expected to provide lower-cost choices for individuals seeking long-term therapy. These factors are likely to present market participants with lucrative opportunities.

However, the availability of alternatives such as continuous glucose monitoring devices may hinder market growth in this region over the forecast period. In addition, auto-injectors are less painful than syringes, which boosts their popularity. The availability of alternatives such as oral pills, on the other hand, may stifle innovation. Higher injector pricing, a lack of self-injection practices in this nation, and the availability of replacement goods are all factors limiting the Asia pacific auto-injectors market's development.

This research report on the APAC Autoinjectors market has been segmented & sub-segmented the market into the following categories:

By Product:  

  • Fillable Autoinjectors
  • Prefilled Autoinjectors

By Usability: 

  • Disposable Autoinjectors
  • Reusable Autoinjectors

By Manufacturing Design: 

  • Standardized Autoinjectors
  • Customized Autoinjectors

By Technology: 

  • Automated Autoinjectors
  • Manual Autoinjectors

By Application: 

  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regionally, Asia-Pacific is growing fastest due to the rising population, chronic diseases, and emerging economies like China and India. The high diabetic population and rising healthcare expenditures in the Asia Pacific are driving market growth, attracting several prominent autoinjector device manufacturers to the area. These firms are expanding their presence in the Asia Pacific market in various ways, including opening sales offices and forming partnerships with local pharmaceutical companies.

Due to the rising prevalence of diabetes and anaphylaxis due to food allergies in countries such as India, China, Japan, Singapore, and Australia, Asia Pacific is expected to expand at the quickest CAGR. The rising prevalence of type 1 diabetes is expected to fuel market expansion. In addition, the demand in this region is expanding due to the region's growing elderly population, which has led to an increase in the incidence of illnesses, including diabetes and cancer.

On the other hand, the market is being pushed by improved healthcare infrastructure, which is being supported by increasing technological advancements in this field. During the forecast period, Asia Pacific is anticipated to have the quickest revenue growth rate compared to other regional markets in the worldwide market.

During the forecast period, the Indian autoinjectors market is predicted to be growing at the fastest CAGR among all the APAC countries.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in the APAC Autoinjectors market profiled in this report are Mylan N.V., Pfizer, Inc., Bayer AG, Becton, Dickinson and Company, Novartis AG, Biogen Idec, Inc., Janssen North America Services, LLC, Sanofi, Unilife Corporation and Eli Lilly.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Fillable Autoinjectors          

                                5.1.3 Prefilled Autoinjectors       

                                5.1.4 Y-o-Y Growth Analysis, By Product               

                                5.1.5 Market Attractiveness Analysis, By Product             

                                5.1.6 Market Share Analysis, By Product               

                5.2 Usability                       

                                5.2.1 Introduction           

                                5.2.2 Disposable Autoinjectors  

                                5.2.3 Reusable Autoinjectors     

                                5.2.4 Y-o-Y Growth Analysis, By Usability              

                                5.2.5 Market Attractiveness Analysis, By Usability            

                                5.2.6 Market Share Analysis, By Usability              

                5.3 Manufacturing Design                           

                                5.3.1 Introduction           

                                5.3.2 Standardized Autoinjectors             

                                5.3.3 Customized Autoinjectors

                                5.3.4 Y-o-Y Growth Analysis, By Manufacturing Design   

                                5.3.5 Market Attractiveness Analysis, By Manufacturing Design 

                                5.3.6 Market Share Analysis, By Manufacturing Design  

                5.4 Technology                 

                                5.4.1 Introduction           

                                5.4.2 Automated Autoinjectors

                                5.4.3 Manual Autoinjectors        

                                5.4.4 Y-o-Y Growth Analysis, By Technology        

                                5.4.5 Market Attractiveness Analysis, By Technology      

                                5.4.6 Market Share Analysis, By Technology        

                5.5 Application                 

                                5.5.1 Introduction           

                                5.5.2 Anaphylaxis            

                                5.5.3 Multiple Sclerosis 

                                5.5.4 Rheumatoid Arthritis          

                                5.5.5 Y-o-Y Growth Analysis, By Application         

                                5.5.6 Market Attractiveness Analysis, By Application       

                                5.5.7 Market Share Analysis, By Application        

                5.6 Distribution Channels                             

                                5.6.1 Introduction           

                                5.6.2 Hospitals  

                                5.6.3 Retail         

                                5.6.4 Online Pharmacies               

                                5.6.5 Others      

                                5.6.6 Y-o-Y Growth Analysis, By Distribution Channels    

                                5.6.7 Market Attractiveness Analysis, By Distribution Channels  

                                5.6.8 Market Share Analysis, By Distribution Channels    

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Usability

                                                6.1.3.4 By Manufacturing Design

                                                6.1.3.5 By Technology

                                                6.1.3.6 By Application

                                                6.1.3.7 By Distribution Channels

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Usability

                                                6.1.4.4 By Manufacturing Design

                                                6.1.4.5 By Technology

                                                6.1.4.6 By Application

                                                6.1.4.7 By Distribution Channels

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Usability

                                                6.1.5.4 By Manufacturing Design

                                                6.1.5.5 By Technology

                                                6.1.5.6 By Application

                                                6.1.5.7 By Distribution Channels

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Mylan N.V.                 

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer, Inc.,                 

                8.3 Bayer AG                     

                8.4 Becton, Dickinson and Company                       

                8.5 Novartis AG                

                8.6 Biogen Idec, Inc.,                     

                8.7 Janssen Global Services                        

                8.8 Sanofi                           

                8.9 Eli Lilly and Company                              

                8.10 Unilife Corporation                               

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  •  Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms Technology with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Autoinjectors Market, By Product, From 2021 to 2026 (USD Billion)
  2. Asia Pacific Fillable Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  3. Asia Pacific  Prefilled Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  4. Asia Pacific Autoinjectors Market, By Usability, From 2021 to 2026 (USD Billion)
  5. Asia Pacific Disposable Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  6. Asia Pacific Reusable Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  7. Asia Pacific Autoinjectors Market, By Manufacturing Design, From 2021 to 2026 (USD Billion)
  8. Asia Pacific Standardized Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  9. Asia Pacific Customized Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  10. Asia Pacific Autoinjectors Market, By Technology, From 2021 to 2026 (USD Billion)
  11. Asia Pacific Automated Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  12. Asia Pacific Manual Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  13. Asia Pacific Autoinjectors Market, By Application, From 2021 to 2026 (USD Billion)
  14. Asia Pacific Anaphylaxis Market By Region, From 2021 to 2026 (USD Billion)
  15. Asia Pacific Multiple Sclerosis Market By Region, From 2021 to 2026 (USD Billion)
  16. Asia Pacific Rheumatoid Arthritis Market By Region, From 2021 to 2026 (USD Billion)
  17. Asia Pacific Autoinjectors Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  18. Asia Pacific Hospitals Market By Region, From 2021 to 2026 (USD Billion)
  19. Asia Pacific  Retail Market By Region, From 2021 to 2026 (USD Billion)
  20. Asia Pacific Online Pharmacies Market By Region, From 2021 to 2026 (USD Billion)
  21. Asia Pacific Others Market By Region, From 2021 to 2026 (USD Billion)
  22. Japan Autoinjectors Market, By Product, From 2021 to 2026 (USD Billion)
  23. Japan Autoinjectors Market, By Usability, From 2021 to 2026 (USD Billion)
  24. Japan Autoinjectors Market, By Manufacturing Design, From 2021 to 2026 (USD Billion)
  25. Japan Autoinjectors Market, By Technology, From 2021 to 2026 (USD Billion)
  26. Japan Autoinjectors Market, By Application, From 2021 to 2026 (USD Billion)
  27. Japan Autoinjectors Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  28. China Autoinjectors Market, By Product, From 2021 to 2026 (USD Billion)
  29. China Autoinjectors Market, By Usability, From 2021 to 2026 (USD Billion)
  30. China Autoinjectors Market, By Manufacturing Design, From 2021 to 2026 (USD Billion)
  31. China Autoinjectors Market, By Technology, From 2021 to 2026 (USD Billion)
  32. China Autoinjectors Market, By Application, From 2021 to 2026 (USD Billion)
  33. China Autoinjectors Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  34. India Autoinjectors Market, By Product, From 2021 to 2026 (USD Billion)
  35. India Autoinjectors Market, By Usability, From 2021 to 2026 (USD Billion)
  36. India Autoinjectors Market, By Manufacturing Design, From 2021 to 2026 (USD Billion)
  37. India Autoinjectors Market, By Technology, From 2021 to 2026 (USD Billion)
  38. India Autoinjectors Market, By Application, From 2021 to 2026 (USD Billion)
  39. India Autoinjectors Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  40. Australia Autoinjectors Market, By Product, From 2021 to 2026 (USD Billion)
  41. Australia Autoinjectors Market, By Usability, From 2021 to 2026 (USD Billion)
  42. Australia Autoinjectors Market, By Manufacturing Design, From 2021 to 2026 (USD Billion)
  43. Australia Autoinjectors Market, By Technology, From 2021 to 2026 (USD Billion)
  44. Australia Autoinjectors Market, By Application, From 2021 to 2026 (USD Billion)
  45. Australia Autoinjectors Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  46. South Korea Autoinjectors Market, By Product, From 2021 to 2026 (USD Billion)
  47. South Korea Autoinjectors Market, By Usability, From 2021 to 2026 (USD Billion)
  48. South Korea Autoinjectors Market, By Manufacturing Design, From 2021 to 2026 (USD Billion)
  49. South Korea Autoinjectors Market, By Technology, From 2021 to 2026 (USD Billion)
  50. South Korea Autoinjectors Market, By Application, From 2021 to 2026 (USD Billion)
  51. South Korea Autoinjectors Market, By Distribution Channels, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample